[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,555,576
  • Shares Outstanding, K 130,291
  • Annual Sales, $ 642,820 K
  • Annual Income, $ -43,540 K
  • EBIT $ -88 M
  • EBITDA $ -45 M
  • 60-Month Beta 2.03
  • Price/Sales 11.37
  • Price/Cash Flow N/A
  • Price/Book 8.85

Options Overview Details

View History
  • Implied Volatility 73.14% (-5.08%)
  • Historical Volatility 81.56%
  • IV Percentile 16%
  • IV Rank 35.77%
  • IV High 112.74% on 11/19/25
  • IV Low 51.09% on 08/21/25
  • Expected Move (DTE 2) 2.98 (5.35%)
  • Put/Call Vol Ratio 2.31
  • Today's Volume 420
  • Volume Avg (30-Day) 614
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 13,662
  • Open Int (30-Day) 11,134
  • Expected Range 52.66 to 58.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.26
  • Number of Estimates 6
  • High Estimate $-0.20
  • Low Estimate $-0.30
  • Prior Year $-0.22
  • Growth Rate Est. (year over year) -18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.93 +32.67%
on 07/21/26
60.69 -8.34%
on 08/11/26
+11.89 (+27.18%)
since 07/17/26
3-Month
20.88 +166.43%
on 05/19/26
60.69 -8.34%
on 08/11/26
+34.18 (+159.35%)
since 05/18/26
52-Week
11.16 +398.48%
on 10/14/25
60.69 -8.34%
on 08/11/26
+42.17 (+313.30%)
since 08/18/25

Most Recent Stories

More News
5 Revealing Analyst Questions From 10x Genomics’s Q2 Earnings Call

5 Revealing Analyst Questions From 10x Genomics’s Q2 Earnings Call

TXG : 55.63 (-4.07%)
1 High-Flying Stock to Own for Decades and 2 We Question

1 High-Flying Stock to Own for Decades and 2 We Question

TXG : 55.63 (-4.07%)
PAY : 38.32 (-5.76%)
NBR : 93.86 (-2.95%)
TXG Q2 Deep Dive: Atera Launch Signals Transition as Spatial Market Shifts

TXG Q2 Deep Dive: Atera Launch Signals Transition as Spatial Market Shifts

TXG : 55.63 (-4.07%)
1 Unpopular Stock That Deserves Some Love and 2 That Underwhelm

1 Unpopular Stock That Deserves Some Love and 2 That Underwhelm

TXG : 55.63 (-4.07%)
NPO : 329.43 (-4.88%)
ODFL : 208.00 (-1.87%)
10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations

10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations

TXG : 55.63 (-4.07%)
10x Genomics: Q2 Earnings Snapshot

10x Genomics: Q2 Earnings Snapshot

TXG : 55.63 (-4.07%)
10x Genomics Launches Atara Platform but Revenue Growth Still Depends on Second Half Execution

Barchart Research What to Expect from TXG Earnings TXG Generated August 5, 2026 Current Price $47.46 EPS Estimate $$-0.23 Consensus Rating Moderate Buy Average Move 4.94% 10x Genomics Launches Atara Platform...

TXG : 55.63 (-4.07%)
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

TXG : 55.63 (-4.07%)
1 Surging Stock with Solid Fundamentals and 2 Facing Headwinds

1 Surging Stock with Solid Fundamentals and 2 Facing Headwinds

TXG : 55.63 (-4.07%)
BRK.A : 753,600.00 (+0.83%)
PEBO : 40.99 (-0.19%)
10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care

Collaboration aims to identify biomarkers predictive of treatment response across multiple cancer types using 10x's single cell and spatial platforms

TXG : 55.63 (-4.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 61.42
2nd Resistance Point 60.11
1st Resistance Point 57.87
Last Price 55.63
1st Support Level 54.32
2nd Support Level 53.01
3rd Support Level 50.77

See More

52-Week High 60.69
Last Price 55.63
Fibonacci 61.8% 41.77
Fibonacci 50% 35.92
Fibonacci 38.2% 30.08
52-Week Low 11.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.